(Watch Live) The coordinator of the White House’s coronavirus task force participated in the 2020 International AIDS Conference that is taking place this week. Dr. Deborah Birx during a pre-taped interview with Liz Schrayer, president of the U.S. Global Leadership Coalition, a group that promotes American diplomacy and international development efforts, that was shown on Tuesday drew parallels between the fights against the coronavirus and HIV/AIDS pandemics.  Birx discussed public health messaging around the pandemic, noting it 'doesn’t help to keep saying the same three things over and over again if people aren’t hearing you and being able to apply that to their lives. Birx also said the countries that have had the highest COVID-19 mortality rates has surprised her, including the USA

(Watch Live) Minnesota diabetics who need emergency insulin supplies but can’t afford them will be able to get the drug starting Yesterday under a new state law. The safety net program within the Alec Smith Insulin Affordability Act, which the Legislature passed in April, will allow qualifying diabetics with less than seven days worth of the lifesaving drug left to pay no more than $35 to get a one-time 30-day supply from their pharmacy. As soon as the bill went into effect, however, drug companies filed a lawsuit stating that the law infringes upon their right to sell their property. 

(Watch Live) In a hauntingly familiar announcement, scientists have identified a new strain of swine flu that has all the hallmarks of a potential pandemic. This new disease, called G4 EA H1N1, was first identified in China’s pig farms where an estimated 10% of industry workers have already been exposed. Notably, unlike COVID, the incidence of infection increased among younger workers, indicating ‘increased human infectiion rates.’ Unfortunately, while existing flu vaccines are designed to protect against H1N1, present vaccines will provide no protection against G4 viruses.

(Watch Live) As one of the only drugs shown to alter the course of COVID-19, antiviral Rem-des-i-vir is in high demand. In a controversial move that unmistakably resembles price gouging, Gilead Sciences announced Monday an official price-point of $2,340 per patient for wealthier nations. This price covers the full treatment for the virus and works out to be around $100 per pill in total.

(Watch Live) Former Executive Director of America HIV Medicine & Gay Doctor, Howard Grossman is asks the most important VIEWERS QUESTIONS on Coronavirus and what's next ...Read More